1 Followers
26 Following
satish

satish

Myeloproliferative Neoplasms Treatment Market Accelerates Business to Gain High Revenue during 2018-2026

Myeloproliferative Neoplasms (MPNs) are a group of rare disease, in which the bone marrow produces excess blood cells. It can be white blood cells, red blood cells or platelets. The overproduction of blood cells by the bone marrow creates hindrance in the smooth flow of blood, which leads to various symptoms such as progressive cytopenias, cachexia and weight loss, splenomegaly, and blastic transformation. These conditions are developed gradually over a period of time. Most people are diagnosed after the age of 60 years, when they were accompanied by many other health issues, makes the treatment more difficult.

 

The major symptoms associated with MPNs include bleeding problem, anemia, chest pain, fatigue, enlarged spleen, and weight loss. According to Annals of Hematology, approximately 90% of patients has experienced MPN-symptoms in past 12 months, wherein women are reported to have higher overall burden than men. The treatment for myeloproliferative neoplasms is mainly aimed to reduce the excess number of blood cells circulation. The concept of myleoproliferative disease was first given by hematologist Williom Dameshek in 1950. However, in 2008, World Health Organization (WHO) classified hematologic malignancies and renamed myloproliferative diseases to myeloproliferative neoplasms.

 

Request For a Sample Copy of This Research Report:https://www.coherentmarketinsights.com/insight/request-sample/930

 

Rising awareness of molecular abnormalities and cellular pathways involved in the pathogenesis of MPNs is expected to facilitate the development of novel drugs, propels the Myeloproliferative Neoplasms treatment market growth in the near future

Myeloproliferative neoplasm can significantly affect the quality of life of the patient. The complication and treatments as well as the physiological strains of cancer diagnosis can affect the physical and emotional wellbeing of patients. Effects of complication vary from depression, fatigue, pain or depression with suicidal ideation. Moreover, patients can experience few or no symptoms for a longer period of time. MPNs can be cured with proper monitoring and treatment. There has been a major revolution in the management of MPNs by introduction of JAK1 and JAK2 inhibitor and ruxolitinib. Ruxolitinib inhibits these two enzymes in order to manage MPNs. The drug has also been proven as an alternative therapy for the treatment of polycythemia vera. Further, the therapeutic armamentarium for MPN is still inadequate for normalization of life span, reduction in cardiovascular complications, and prevention of hematological progression.

 

Rising awareness of molecular abnormalities and cellular pathways involve in the pathogenesis of MPNs is expected to facilitate the development of clinical trials with novel drugs, either alone or in combination with ruxolitinib. Interferon (IFN) is a drug that has proven as an effective alternative for MPNs patients. Better understanding of its mechanism of action for MPNs could lead to better interferon compound and potential drugs. In 2017, MPN research foundation have initiated a MPNRF Interferon (IFN) multi-center project which is expected to bring together internationally recognized experts to determine cytokine-driven pathways that affect the path of the MPNs. It is a closely-related group of progressive blood cancer which is also among the lucrative opportunities for major players in the Myeloproliferative Neoplasms treatment market.

 

Collaboration among the biotech and pharmaceutical companies to identify new drugs for MPNs is expected to accelerate the market growth

Novartis AG and Incyte Corporation are among the key players in Myeloproliferative Neoplasms treatment market. According to MPN research foundation, biotech and pharmaceutical companies are expected to propel the demand for improved treatments and quickly connecting patients with latest treatment options. It is expected to lead developing relationships with biotech and pharmaceuticals companies to identify new areas for scientific exploration. For instance, Incyte Corporationis is developing inhibitor for Janus Kinase (JAK) and also focusing on the discovery, development, and commercialization of proprietary therapeutics globally.

 

Click To Read More On Myeloproliferative Neoplasms Treatment

Ophthalmic Femtosecond Lasers Market Present Chances, Trends, Value Chain And Stakeholder Analysis 2018-2026

Femtosecond laser are ultrafast and ultrashort lasers that release optical pulses 10-15/seconds. The generation of short pulses are achieved by using the passive mode locking technique. This technique is used for generating pulses of light in very short duration (such as for picosecond or femtosecond durations). The femtosecond lasers are popular among ophthalmologists, as such devices help in simplifying and avoiding complex processes of open surgeries. Flap creation in laser in situ keratomileusis (LASIK) is the most common use of this type of laser. It can also be used for other corneal refractive procedures, cataract surgery, and lamellar and full thickness corneal transplantation.

 

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/385

 

The femtosecond laser allows thin and uniform flaps that improve the stability, safety, and precision of the flaps. Added advantage of the femtosecond laser is that it allows the medical doctor to select the cutting angle, position, and diameter of the hinge, as well as the flap diameter and flap thickness, which may offer better flap stability and reduce clinical epithelial ingrowth.

According to Centre for Disease Control and Prevention (CDC), cataract is the prominent blinding condition in the 116 countries enclosed by the Blindness Data Bank in the World Health Organization (WHO) Program for the Prevention of Blindness, nearly 42 million people were affected by severe loss of vision, with cataract being the main cause in 17 million of these cases in 2014. Cataract was the prime cause of blindness in 43.6% of country reports in the same year.

 

Potential target population in the U.S.

According to Centre for Disease Control and Prevention in 2015, approximately 20.5 million people in the U.S. suffered from cataract, mainly those aged 40 years and older. One of the foremost drivers for ophthalmic femtosecond lasers market is an increasing incidence rate of cataract and rising geriatric population. Among emerging economies, cataract is the major cause of severe visual impairment. World Health Organization carried out a population-based prevalence survey for blindness, across various regions in Africa that are not endemic for trachoma or onchocerciasis, and discovered a blindness rate of around 1%, with cataract accounting for 40%-50% of visual loss cases.

 

Refractive error can include near-sightedness (myopia), astigmatism or presbyopia, farsightedness (hyperopia). There are several surgical actions for correcting or adjusting eye's focusing ability by reshaping the cornea, or clear, round dome at the front of your eye. Other procedures involve implanting a lens inside your eye. According to Centres for Disease Control and Prevention (CDC):

 

Factors impeding ophthalmic femtosecond lasers market growth

Major factors which are hindering the growth of this market are shortage of ophthalmologists. Owing to the presence of key players in North America occupied the leading position in this market with largest share. Over the impending years, the strong focus of these players on R & D, the availability of healthcare infrastructure and a well-established regulatory structure for timely approval of the products are likely to support this regional market to retain its position.

 

Due to large base of the population, China is expected to emerge as the most attractive domestic market for ophthalmic lasers in Asia Pacific. The Middle East and Africa and Latin America are also projected to witness a considerable rise in their respective markets for ophthalmic lasers in the near future, due to the thriving medical tourism and the low cost of laser eye surgeries in these regions.

Key players operating in the global ophthalmic femtosecond lasers market are IMRA America, Inc., Newport Corporation, Abbott Medical Optics, Alcon, Bausch & Lomb, Carl Zeiss Meditec, and Ziemer Ophthalmic Systems.

 

Click To Read More On Ophthalmic Femtosecond Lasers Market

Fetal Monitoring Analysis and In-depth Research on Market Size,Emerging Growth Factors

Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe and healthy. These are also used to monitor chronic mental retardation, hypothermia, lung diseases, neonatal diseases, vision & hearing problems, and jaundice.

Fetal monitoring is usually done using handheld doppler device or an electronic fetal monitor. Fetal monitoring is necessary to avoid complications during labor or if patient gets an epidural or if oxytocin is required to induce or augment labor. Moreover there are two ways to perform fetal monitoring namely, external and internal. Fetal monitoring is especially helpful if the patient is expected to have a high-risk pregnancy, especially women suffering from high blood pressure or diabetes.

 

Download The PDF Brochure: https://www.coherentmarketinsights.com/insight/request-pdf/466

 

Increase in birth rate fuels the growth of fetal monitoring market

The boost in fetal monitoring market is due to increased rate of birth and pre-term births. Various government and nongovernment organizations are actively taking initiatives to provide better maternal and fetal care. However, rise in number of problems during pregnancy due to high-blood pressure, diabetes, pre-term labor medicine affect the fetus. So, fetal monitoring device are used routinely by gynecology and obstetrics interventions to examine fetal health during labor and delivery.

Furthermore, advancement in technology such as wireless or real time analysis also expands the market of fetal monitoring devices. The demand of fetal monitoring device is also increased significantly in past few years to reduce intrapartum stillbirths. According to WHO, annually 15 million babies are born pre-term which leads to death. Pre-term babies live only till approx. 5 years of age which is also responsible for nearly 1 million deaths in 2015.

 

Regional growth engines for fetal monitoring market

Asia Pacific is an emerging region for fetal monitoring market, as healthcare awareness is on the rise in the region and the region is the most populous. However, according to stats mention in World Population Prospects: 2015 Revision, the total fertility was pegged at 2.5 children per woman globally. However, there is wide regional difference across the globe that is further expected to offer irregular scenario over the forecast period in fetal monitoring industry.

 

Major acquisitions to support growth of fetal monitoring market

Rise in support from government for enhanced maternal facilities such as subsidies given by government to expand care in rural area to private not-for-profit organization, in countries like Uganda as they have poor healthcare facilities. Whereas, the Government of the Philippines has also placed health and maternal health high on its political agenda of reform.

Moreover, rising investment of company for development of new features for fetal monitoring devices expects to increase the working efficiency of company and broadens its product portfolio. Key players in the fetal monitoring market include ArjoHuntleigh, Inc. (U.S.), C FUJIFILM SonoSite, Inc. (U.S.), GE Healthcare (U.K.), Natus Medical Incorporated (U.S.), Neoventa Medical (Sweden), ovidien PLC (U.S.), Philips Healthcare (Netherlands), Siemens Healthcare (Germany), Analogic Corporation (U.S.), and Spacelabs Healthcare Inc. (U.S.).

 

Click To Read More On Fetal Monitoring Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Global Dental Implants Market Overview, Industry Top Manufactures, Market Size, Industry Growth Analysis and Forecast: 2026

Dental implants are implants in the jaw, placed below the gum line, providing a base for planting artificial teeth or bridge. Dental implants market has witnessed drastic rise in the last few years. A number of socioeconomic and technological factors have contributed to overall growth of the industry. Europe and North America account for 65.9% of global dental implants market revenue in 2016. However, market dynamics are expected to witness a major shift, with Asia Pacific and Latin America emerging as the fastest growing markets for dental implant over the forecast period (2016–2024). This is primarily attributed to aging baby boomers population with high spending power. Lately, the industry is witnessing change in market dynamics post-economic recession of 2008. The industry that was once fragmented is slowly shifting towards consolidation. One such example is the acquisition of Astra by DENTSPLY in 2011.

 

Market Dynamics

With changing market dynamics, companies are emphasizing on product innovation and strengthening of distribution channel to sustain and expand their business reach worldwide. Various macroeconomic factors such as increased geriatric population, growing focus on aesthetics, rise in out-of-pocket spending, and establishment of quality healthcare institutions are expected to bolster sales of dental implant devices worldwide. On an average, over 20% of population in EU is aged over 65 years. Moreover, EU spends nearly 9% of its GDP on healthcare. Increasing consolidation, technological advancement, and company laying emphasis on strengthening distribution channels are some of the key dental implants market trends.

 

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/89

 

Market Taxonomy

This report segments the dental implants market on the basis of product type, technique, population demographics, and end use. On the basis of product type, the market is segmented into titanium and zirconium. On the basis of technique, the dental implants market is segmented as root form and plate form. On the basis of population demographics, the market is segmented into geriatric, middle-aged, adult, and others. On the basis of end-use, the dental implants market is segmented as dental labs, hospitals, and others.

 

Key features of the study:

This report provides in-depth analysis of the dental implants market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2016 – 2024), considering 2015 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

The report takes into account critical limiting factors such as accuracy issues and need for calibrating the device several times a day while analyzing the market value and growth (%) during the forecast period

It includes insights on population dynamics, number of dental clinic centers, and demand for dental implants across the globe.

 

Europe is expected to dominate the market throughout the forecast period. The region is expected to account for 30.8% of overall market share by 2024. Competition in dental implants market has increased primarily between Straumann and DENTSPLY Implants. According to Europa, over 25% of the population in Europe is expected to fall under geriatric age group by 2020. This coupled with high discretionary income in the region is expected to continue to position the region as a highly lucrative market for dental implants. Germany is one of the key markets for dental implants. The country spends highest per capita income on teeth than any other country in Europe.

 

Among product type, titanium dental implants segment is expected to hold dominant position in the dental implants market over the forecast period. The segment accounted for 44.7% of global market revenue in 2015. However, zirconia dental implants segment is expected to hold dominant position in the market by 2024. Key players are launching mini-titanium dental implants solutions, which are compatible with biologically active drugs that are usually incorporated on the surface of implant to improve osseointegration. The consumers mostly prefer titanium dental implants, as it has longer lifespan.

 

Emerging economies to present highly lucrative growth avenues

Dental implant players are focused towards strengthening of direct distribution channel along with partnership with regional manufacturers and distributors. DENTSPLY Implants, Straumann AG, Bicon Dental Implants, Anthogyr, KYOCERA Medical Corporation, Lifecore Dental Implants, Zest Anchors, Implant Innovations Inc, and BioHorizons IPH, Inc., Neobiotech USA. Inc., Sweden & Martina, TBR Implants Group, Global D, and MOZO-GRAU, S.A. are some of the key industry players in dental implants market.

 

Click To Read More On Global Dental Implants Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

 

Abdominal Aortic Aneurysm Repair Devices Industry: Study Growth Factors, Types and Applications with Market Forecasts 2026

Abdominal Aortic Aneurysm (AAA) refers to the enlargement in part of the aorta, the main blood vessel that delivers blood to the body, which passes through the abdomen. AAA usually affects people over 50 years and is more common in men as compared to women. Others risk such as smoking and high blood pressure can also cause AAA. Previously, AAA was treated with open surgery, however, it has been replaced with endovascular stent grafting. Endovascular stent grafting is a minimally invasive procedure and has various advantages over open surgery such as reduced blood loss, operative time, hospital stay, mortality, and morbidity.

 

Request For Sample Copy of This Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1568

 

Abdominal Aortic Aneurysm Repair Devices Market Drivers

Key players in the abdominal aortic aneurysm repair devices market have launched various new products for AAA treatment and this has positively affected growth of the market. For instance, in 2017, Lombard Medical Inc. received approval from the Japanese Ministry of Health, Labour and Welfare for its new IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2016, Lombard Medical, Inc. received CE Mark approval for its IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2013, Lombard Medical Inc. launched its Aorfix, a latest endovascular stent graft in the U.S. market. In 2014, Cordis Corporation (now a part of Cardinal Health, Inc.) launched its INCRAFT AAA Stent Graft System (INCRAFT System), a device for use during endovascular aneurysm repair (EVAR) for patients suffering from infrarenal AAA.

 

North America is expected to hold a dominant position in the global abdominal aortic aneurysm repair devices market, owing to presence of major players and frequent launches of novel devices in market. For instance, Medtronic Plc., Cardinal Health, Inc., and Boston Scientific Corporation, the major players in the market are headquartered in the U.S.

 

Asia Pacific is also expected to exhibit high growth in the global abdominal aortic aneurysm repair devices market, owing to increasing approvals of novel devices by major regulatory bodies in the region. For instance, in Lombard Medical, Inc. received approval for its new AorFlex delivery system from the Japanese Ministry of Health, Labour and Welfare. AorFlex is a delivery system for Aorfix endovascular stent graft indicated for the treatment of AAA.

 

Key players in the abdominal aortic aneurysm repair devices market have launched various new products for AAA treatment and this has positively affected growth of the market. For instance, in 2017, Lombard Medical Inc. received approval from the Japanese Ministry of Health, Labour and Welfare for its new IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2016, Lombard Medical, Inc. received CE Mark approval for its IntelliFlex Low Profile (LP) Delivery System for the Aorfix Endovascular Stent Graft. In 2013, Lombard Medical Inc. launched its Aorfix, a latest endovascular stent graft in the U.S. market.

 

Abdominal Aortic Aneurysm Repair Devices Market Key Players

Major players operating in global abdominal aortic aneurysm repair devices market includes: Medtronic Plc., Cardinal Health Inc., Lombard Medical Inc., Endologix, Inc., Cook Group Incorporated, Boston Scientific Corporation, Terumo Corporation, and W. L. Gore & Associates, Inc. Key players in the market are focusing on strategic collaborations and acquisitions, in order to expand its abdominal aortic aneurysm repair devices portfolio and geographic reach.

 

Click To Read More On Abdominal Aortic Aneurysm Repair Devices Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Interventional Cardiology Devices Market: Growth, Development, Trends, Demand, Share, Analysis and Forecast 2026

Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.

 

Request For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/691

 

Interventional cardiology devices market taxonomy:

By Product Type

  • Stents

  • Catheters

  • Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons

  • Intravascular Ultrasound System

  • Inferior Vena Cava (IVC) Filter

  • Percutaneous Transluminal Coronary Angiography (PTCA) Guide Wires

  • Left atrial Appendage (LAA) Device

By Geography

  • North America

  • Latin America

  • Europe

  • Asia Pacific

  • Middle East

  • Africa

Increased prevalence of cardiovascular diseases is expected to fuel the growth of interventional cardiology devices market

There is a continuous increase in geriatric population and obesity which is leading  to the increase in cardiovascular disease. For instance, as per United Nations report, there were around 901 million people of age 60 and above in 2015 and it is expected to reach 1.4 billion by 2050. Advancement in healthcare research, increasing patient awareness, and increase in the demand for minimal invasive surgery raise the demand for interventional cardiology devices. Interventional cardiology devices help interventional cardiologist to perform the procedure in short span of time, which reduces the risk and complication. The increase in obesity, geriatric population and lifestyle changes leads to the increase in coronary artery disease, for instance as per American Heart Association 2017 report, in the U.S. there was around 360,000 death caused due to coronary artery disease. With the prevalence of lifestyle diseases such as diabetes and hypertension has increased the cases of cardiovascular disorders.

 

Developed regions support the growth of interventional cardiology devices market

Interventional cardiology devices market is segmented into various geographical regions such as North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America leads the interventional cardiology devices market because of the large geriatric population and sedentary lifestyle leading to cardiovascular disorders. According to Population Reference Bureau 2016, there were around 40 million people of age 60 and above, and it is expected to reach 89 million by 2050 in the U.S. Europe is closely following the North America in interventional cardiology devices market followed by Asia Pacific. However, Asia Pacific is expected to expand significantly in near future because of emerging economies such as India and China due to the increase in cardiovascular diseases, increased healthcare expenditure, per capita income of individual and increase in geriatric population, which is expected to support the growth of interventional cardiology devices market.

 

Key players to support the interventional cardiology devices market

There are various players present across the globe contributing to the interventional cardiology devices market. Some key players are Abbott, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical and B. Braun Melsungen AG. In 2017, Abbott acquired St Jude Medicals to increase the product pipeline, as St Jude Medicals are into atrial fibrillation, structural heart, heart failure and chronic pain and Abbott are leading in coronary inventions, which increase the market share and fuels the growth of interventional cardiology devices market.

 

Click To Read More On Interventional Cardiology Devices Market

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Hemophilia Gene Therapy Market: Competitive Dynamics & Global Outlook 2026

Hemophilia Gene Therapy Market

Hemophilia is a genetic disorder in which patient’s blood do not clot normally due to lack of blood-clotting proteins known as coagulating factors. Conventional treatment options include timely replacement of the specific clotting factor. Major pharma and biotech companies are conducting research and development to develop gene therapy for hemophilia due to various shortcomings with conventional therapy. Increasing number of hemophilic patients that require treatment and strong product pipeline are expected to drive growth of the hemophilia gene therapy market.

 

Market Dynamics

Major factors that are driving growth of the hemophilia gene therapy market include increasing prevalence of hemophilia, issue of high cost, access to current hemophilia treatment, which includes coagulation factor VIII and IX, and increasing number of companies engaged in research and development of gene therapy products. According to the Centers for Disease Control and Prevention, hemophilia A is a rare, X-linked bleeding disorder that affects around 1 in 5,000 to 10,000 live-born males. Hemophilia B is less common than hemophilia A, with an incidence of around 1 in 25,000 births. According to 2016 global survey by the World Federation of Hemophilia, the total number of individuals with hemophilia worldwide was 184,723, including 16,949 within the U.S.

 

Request Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/2480

 

Strong gene-based product pipeline for hemophilia treatment is expected to drive the hemophilia gene therapy market growth

Gene therapy for hemophilia has strong product pipeline, which is expected to enter the market in the near future. This is expected to drive the market growth, as it would result in availability of new treatment options for management of hemophilia. By Januarys 2019, over 15 investigational gene therapy are under the clinical development stage. In December 2018, Spark Therapeutics announced updated preliminary data for the ongoing phase 1/2 clinical trial of investigational SPK-8011 in hemophilia A.

Current therapies for treating hemophilia are only symptomatic management of the disease by administering clotting factors XIII or IX. Furthermore, there are serious adverse effects associated with plasma derived products, and limited access to treatment. Gene therapy may address these issues to certain level. BioMarin Pharmaceutical’s gene therapy product Valoctocogene roxaparvovec for hemophilia A is in phase III of clinical development in 2019.

 

Regulatory bodies such as the U.S. Food and Drug Administration (FDA) are supporting the product development for gene therapy by allotting breakthrough designation status to investigational gene therapy. For instance, in 2017, the U.S. FDA granted breakthrough therapy designation to valoctocogene roxaparvovec, which is an Adeno -associated virus 5 factor VIII vector designed to restore factor VIII plasma concentrations in patients with hemophilia A.

 

Key players operating in the global hemophilia gene therapy market include BioMarin Pharmaceuticals, Inc., Spark Therapeutics, Pfizer, Inc., UniQure NV, Ultragenyx Pharmaceutical, Shire PLC Sangamo Therapeutics, Inc., and Freeline Therapeutics.

 

Click To Read More On Hemophilia Gene Therapy Market

 

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

 

https://www.coherentmarketinsights.com/phase-xs/

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Newborn Screening Market competition by top manufacturers/ Key player/ Economy by Business Leaders

Newborn screening has evolved from a simple urine or blood screening test to a more comprehensive and complex screening system capable of detecting over 50 different conditions. Newborn screening tests measure a number of markers in infant’s blood that can be either decreased or increased if an infant has certain diseases. Currently, conditions such as cystic fibrosis (CF), congenital hypothyroidism, phenylketonuria (PKU), and around 22 other metabolic conditions that affect protein or fat metabolism can be diagnosed through newborn screening tests.

Download The PDF Brochure:www.coherentmarketinsights.com/insight/request-pdf/2546

Market Dynamics
Demand for newborn screening is increasing in order to tackle various infectious diseases such as measles, mumps, polio, tuberculosis, rubella, influenza, whooping cough, chickenpox, malaria, and streptococcal pharyngitis. According to the World Health Organization (WHO) 2018, globally, around 86% of infants are vaccinated against 26 diseases, however, 19.5 million infants are unvaccinated resulting in death of 2-3 million children every year.

Screening of newborn is rapidly gaining traction in Asia Pacific region, owing to highest birth rate in the region, which is almost half of the global population. Therefore, countries in Asia Pacific are focusing on arranging various workshops to discuss and find solutions for increasing incidence of neonatal diseases. For instance, from March 30–April 1, 2008, PerkinElmer, Inc. arranged a workshop on consolidating newborn screening efforts in Cebu, Philippines, in Asia Pacific region. From June 4-5 in 2010, PerkinElmer, Inc. arranged another workshop in Manila, Philippines, which included workshop participants such as service providers, policy-makers, consumer advocates, and researchers from 11 different countries.

Moreover, technological advancements in tandem mass spectrometry, colorimetric analysis test, fluorescence analysis test, enzyme or liquid chromatography, and various immunological assays and other analysis and high adoption rate of newborn screening with new technology are factors that are expected to drive growth of the market. In October 2018, LifeCell International, India’s leading stem cell bank and mother & baby diagnostics company, launched RightStart, the world’s first Integrated DNA testing for newborn screening to detect over 50 medical conditions.

 

Key features of the study:

  • This report provides in-depth analysis of the Asia Pacific newborn screening market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players

Click To Read More On Newborn Screening Market

Palliative Care Market Global Trend, Demand, Growth Analysis and Industry Forecast 2018-2026

Palliative care is specialized medical care for people suffering from serious illness. This type of care is focused on relief from the symptoms and stress of a serious illness. Palliative care is provided by a specially-trained team of doctors, nurses, and other specialists. Palliative care teams specialize in treating people suffering from serious illnesses such as cancer, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), kidney disease, Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis (ALS) and others.

Palliative care market size is increasing in higher income countries such as European countries and Japan due to rising geriatric population suffering from chronic illness. Palliative care also includes equipment such as wheelchairs, walkers, crutches, oxygen equipment, blood pressure monitors, etc.


Request For A Sample Copy Of This Research Report: www.coherentmarketinsights.com/insight/request-sample/2538

Global Palliative Care Market Drivers
The palliative care market revenue is expected to witness significant growth over the forecast period, owing to increasing demand for palliative care centers by patients suffering from chronic illness. For instance, according to Center to Advance Palliative Care (CAPC), in North America, the prevalence of hospitals with a palliative care team increased from 658 to 1,831, which is around 178% increase from 2000 to 2016.

Increasing geriatric population suffering from chronic illness is contributing to the palliative care market size. Palliative care centers are widely involved in taking care of elderly patients affected with chronic illness. According to National Council on Aging 2018 report, around 80% of older adults have at least one chronic disease and 77% have at least two chronic diseases such as heart disease, cancer, stroke, and diabetes.

Global Palliative Care Market: Competitive Landscape
Key players operating in the global palliative care market include Vitas Healthcare Corporation, Skilled Healthcare Group Incorporated, Sunrise Senior Living LLC, Kindred Healthcare Incorporated, Gentiva Health Services Incorporated, Home Instead Senior Care Incorporated, Amedisys Incorporated, and Genesis HealthCare Corporation.

Global Palliative Care Market: Regional Analysis
North America is expected to hold the dominant position in the palliative care market, owing to increased spending on healthcare facilities, infrastructure, and healthcare policies for treatment of chronic diseases. For instance, according to National Health Expenditure Accounts (NHEA), the U.S. health care spending increased 3.9% in 2017 reaching US$ 3.5 trillion or US$ 10,739 per person, compared to 2016 which was US$ 3.3 trillion

 

Click To Read More On Palliative Care Market

Anti-Osteoporosis And Fracture Healing Market Focusing on Companies, Development, Challenges, Growth, Revenue & Forecast 2026

Osteoporosis involves a condition, which results when the rate of bone tissue regeneration is much less than its breakdown, making the bones porous. Osteoporosis is more prevalent in female, where more cases occur after menopause due to decrease in estrogen hormone levels. In osteoporosis, the strength and structure of bones is affected, which increases the probability of occurrence of fractures, especially in hip region, wrists, and spine. An X-ray based scanning method, Dual Energy X-ray Absorptiometry (DEXA) or bone densitometry, is used for diagnosis of the condition. Osteoporosis has no clear symptoms, although is characterized by spine weakening and joint pain.


Request For A Sample Copy Of This Research Report:www.coherentmarketinsights.com/insight/request-sample/2525

Anti-Osteoporosis and Fracture Healing Market Drivers
In the recent past, various regulatory bodies such as European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA), and others approved new drugs for treatment of osteoporosis. Approval and launch of such new drugs are expected to drive global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period. For instance, in April 2017, Radius Health Inc., a biopharmaceutical company, received approval from U.S. Food and Drug Administration (FDA) for TYMLOS (abaloparatide) injection, for treating postmenopausal women with osteoporosis who are at high risk of fracture. This drug reduces the occurrence of spinal cord and peripheral skeleton fractures in postmenopausal women.

Anti-Osteoporosis and Fracture Healing Market Restraints
Bisphosphonate pills, a commonly used medication for osteoporosis are not well absorbed in the stomach and are involved with side effects such as stomach upset and heartburn. In addition to this, increased awareness regarding osteoporosis, especially in women, has resulted in consumption of calcium and vitamin rich diet and adapting physiotherapeutic measures for prevention of occurrence of osteoporosis. These factors are expected to restrain global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period.

Anti-Osteoporosis and Fracture Healing Market Key Players
Some of the key players operating in the anti-osteoporosis and fracture healing market are Radius Health Inc., Pfizer Inc., Amgen Inc., Novartis AG, GlaxoSmithKline Plc., Merck & Co., Inc., F. Hoffman-La Roche AG, Eli, Lilly and Company Limited, and PhytoHealth Corporation.

Anti-Osteoporosis and Fracture Healing Market Regional Analysis
North America anti-osteoporosis and fracture healing market is expected to witness significant growth over the forecast period owing to new product launches. For instance, in September 2018, Zydus Pharma Inc. received approval from U.S. Food and Drug Administration (FDA) for launch of Risedronate Sodium delayed release tablets in America, a drug used for osteoporosis treatment in postmenopausal women.

Click To Read More On Anti-Osteoporosis And Fracture Healing Market

 

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

 

https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Diathermy Equipment Market with Top Key Players data : Development Status Along With Future Trend To 2026

Diathermy is a controlled production of ‘deep heating’ beneath the skin in the subcutaneous tissues, deep muscles, and joints for therapeutic purposes. Using high-frequency short wave electric currents, the heat is generated in the diathermy equipment. The heat can reach areas as deep as two inches beneath the skin’s surface. Diathermy equipment does not apply heat directly to the body. Instead, the waves generated by the machine allow the body to generate heat from within the targeted tissue. Diathermy equipment is used to treat several conditions such as chronic arthritis, fibromyalgia, tendonitis, bursitis, muscle spasms, and increasing blood flow. Diathermy is widely used in surgical procedures to reduce muscle pain and to speed up recovery.


Request For A Sample Copy Of This Research Report:www.coherentmarketinsights.com/insight/request-sample/2519

Global Diathermy Equipment Market: Drivers
The diathermy equipment market size is expected to witness significant growth, owing to increasing prevalence of arthritis and other muscle related disorders and high demand for diathermy treatment. Diathermy treatment for arthritis is very effective and efficient. According to National Health Interview Survey (NHIS) from 2013 to 2015, around 54.4 million U.S. adults (22.7%) were diagnosed with arthritis, rheumatoid arthritis, gout, or fibromyalgia.

Diathermy is an integral part of several modern surgical procedures, which directly contribute to diathermy equipment market revenue. Diathermy equipment are widely used in surgeries for electrosurgical cutting, coagulation, fulguration, and desiccation. According to National Center for Biotechnology Information (NCBI), around 80% of surgical procedures involve the use of diathermy equipment to apply energy to tissues. 

Asia Pacific is expected to witness significant growth in the market, owing to presence of key manufacturers and vendors of diathermy equipment in the region. Majority of market players in the diathermy equipment market such as Zhejiang Jinhua Huatong Medical Appliance Co., Beijing Greenland Science & Technology Developments, Physio International, Medcorpindia, and Micro Electronics Medicines belong to Japan, India, South Korea, and Singapore.

Global Diathermy Equipment Market: Competitive Landscape
Key players operating in the global diathermy equipment market include, Physio International, Zhejiang Jinhua Huatong Medical Appliance Co., Pioneer Health Care, Schiller Healthcare India, Medcorpindia, Tri Tech, Micro Electronics Medicines, United Medical Appliances, Nanjing Fuzhong Medical High-Tech. Co., Beijing Greenland Science & Technology Developments, Life Care Systems, Sunshine Medical Equipment, Sometech Inc., and Spark Meditech.

Download The PDF Brochure: www.coherentmarketinsights.com/insight/request-pdf/2519

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Biopreservation Market: Growth, Development, Trends, Demand, Share, Analysis and Forecast 2026

Biopreservation is the technique that aids in the preservation of bio specimens such as saliva, plasma, and purified DNA. This technique primarily increases the shelf life and ensures stability and purity of the bio specimens. Bio-preservation is used for the storage of cells, tissues, organs and its recent trend includes its use in food safety. The equipment comprises refrigerators, liquid nitrogen and consumables, and media and laboratory information management systems. Biobanking is a type of biopreservation that is widely used in medical research such as genomics research and for personalized medicine.

 

Increasing number of government initiatives for research and development is driving growth of the biopreservation market

Human sperm and egg banks, and demand for preservation of new born stem cells is increasing due to growing awareness about long-term benefits of such preservation such as treatment of diseases, including cancer and autism. Furthermore, increasing adoption of in- house sample storage for further research in hospitals, is in turn increasing growth of the biopreservation market. Increasing number of government initiatives in the form of grants, funds, and contracts to support research activities for the development of various treatments is also expected to boost growth of the market. For Instance, according to the U.K. government policy, 2015, the government is expected to invest US$ 6.8 million in health and research development by 2020.

 

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/748

 

Increasing healthcare expenditure globally and increasing investment in bio-banks and personalized medicines, are also propelling growth of the biopreservation market. Rising incidence of lifestyle-related diseases, cardiovascular diseases, cancer, and hypertension are other factors driving growth of the biopreservation market. According to World Health Organization (WHO), in 2015, cardiovascular diseases caused 31% deaths of all diseases, and 8.8 million people died due to cancer. However, tissue injury during biopreservation, high cost associated with maintenance of these instruments are major factors hampering growth of the market.

 

Market Taxonomy

The global biopreservation market is segmented on the basis of application, product type, bio–specimens, end user, and region.

On the basis of application, the market is segmented into:

Bio Banking, Human Eggs, Human Sperms, Veterinary IVF, Regenerative Medicine, Cell Therapy, Gene Therapy, Drug Discovery

On the basis of product type, the market is segmented into:

Vials, Straws, Bags, Microtiter Plates, Equipment, Freezers, Refrigerators, Consumables, Others

 

Biopreservation market is expected to show a sustainable growth in Asia Pacific due to increasing awareness about preservation of umbilical cord cells

Regional segmentation of the global biopreservation market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the biopreservation market, owing to rapid development of novel drugs, increasing demand for diagnosis of chronic diseases, therapies in healthcare sector are expected to boost market growth. Biopreservation market is driven in the Asia Pacific region due to growing population, rising investments in healthcare research, and growing awareness about preservation of umbilical cord cells. According to New England Journal of Medicines, in 2012, Japan and China had increased their total medical research spending by US$ 9.0 billion and US$ 6.4 billion, respectively and contributed 13.8% and 3.1% of the world’s total medical research expenditure.

 

Broad product portfolio of major players is boosting market growth

Key players operating in the market include Biolife solutions, THERMO- FISHER SCIENTIFIC, BioCision LLC, Simport scientific, Cesca Therapeutics, Atlanta biologics, Lifeline scientific, LabVantage solutions, Hamilton Company, and Core dynamics ltd. Major market players expanding their product portfolio particularly related to media, freezers, refrigerators, consumables, to strengthen their presence in the global market. Click To Read More On Biopreservation Market

 

Global Industrial Microbiology Market Present Chances, Trends, Value Chain And Stakeholder Analysis 2018-2026

Applied Microbiology involves use of microorganisms in various industries, such as pharmaceutical and biotechnology industry, cosmetic industry, food and beverages industry, agriculture and environment, and many others. The use of advanced technology and knowledge about microorganisms in healthcare and environmental issues is of prime importance. In case of pharmaceutical industry the products manufactured using microbiology include amino acids, organic acids, vitamins, nucleotides, antibiotics, insulin and other hormones, polysaccharides, bio surfactants, and hormones. Pharmaceutical microbiological safety, food microbiological safety, cosmetics microbiological safety and contamination control can be assured with the application of microbiology. Application of microorganisms is beneficial as maximum yield of a product can be obtained with the help of customization of the microorganism species such as exposing them to mutagens or by gene amplification. Biomass conversion is another area wherein microorganisms are employed in various processes such as anaerobic digestion, fermentation, pyrolysis, and gasification.

 

Some major players operating in the industrial microbiology market include:

Merck KGaA, bioMérieux SA, Thermo Fisher Scientific Inc., Eppendorf AG, Bruker, Sartorius AG, QIAGEN, Becton Dickinson and Company, Bio-Rad Laboratories Inc., and Mettler-Toledo International Inc.

 

Request Sample Copy of This Research Report:

www.coherentmarketinsights.com/insight/request-sample/981

 

Quality control in pharmaceutical and food industry is of paramount importance, as healthcare is directly associated with the products from these industries. Microbial contamination in injectable, eye drops, drugs, nasal solutions, and food industries can be prevented with the help of micro-organisms by using various tests such as bio burden and growth promotion tests. According to the World Health Organization (WHO), unsafe food contaminated with harmful bacteria, parasites, and viruses can cause more than 200 diseases from diarrhea to cancers. Furthermore, food contamination has cost around 33 Mn of healthy life years according to the WHO. Microorganisms offer properties, such as rapid multiplication and growth rate, biodiversity, great shelf life, and use of byproducts after microbial process is finished, which saves time and cost for various industries. The field has advanced over years with inventions, such as microscope and increasing knowledge about microbial genetic makeup and biological processes associated with microorganisms.

 

Some of the lucrative areas for application of microbiology include bioremediation, bio-fuels production, genetic engineering, green chemistry, and metabolic engineering over the forecast period. Natural fuel consumption has increased exponentially over the past few years, owing to lifestyle changes, increased number of vehicles, and natural fuel resources, which are depleting at faster rates. Wherein bio-fuels can be a remedy. Genetically modified food products can also be an effective remedy against malnutrition in emerging economies such as Africa. Microorganisms are used in biotechnology field, especially in Recombinant DNA technology for various applications, such as crop agriculture, gene therapy, pharmaceutics, vaccine design and bioremediation, and further advancement in the respective areas is expected to boost the market growth over the forecast period.

 

Key features of the study:

 

This report provides in-depth analysis of Industrial Microbiology Market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2017 as the base year.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading player.s

It profiles leading players in the global Industrial Microbiology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.

 

Detailed Segmentation:

Global Industrial Microbiology Market, By Product Type:

Equipments and Systems

Reaction Consumables

Laboratory Supplies

Global Industrial Microbiology Market, By End User:

Pharmaceutical and Biotechnology Industry

Food and Beverages Industry

Cosmetic Industry

Agriculture and Environment

Others

 

Download the PDF brochure:

www.coherentmarketinsights.com/insight/request-pdf/981

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Hematopoietic Stem Cell Transplantation (HSCT) Market Segmentation and Analysis by Recent Trends, Development and Growth by Regions to 2018-2026

Hematopoietic stem cell transplantation is a procedure in which multipotent hematopoietic stem cells sourced from peripheral blood cells, bone marrow or umbilical cord blood are transplanted into a patient. Hematopoietic stem cell transplantation is commonly used in the treatment of lymphoma (Hodgkin, Non-Hodgkin), leukemia, multiple myeloma, thalassemia, sickle cell anemia, and osteoporosis. It includes two transplantation sources namely, autologous that uses stem cells from the patient’s own body and allogeneic that sources stem cells from a donor’s body. According to World Health Organization (WHO), over 50,000 hematopoietic stem cell transplantation procedures are carried out globally, every year and this number is expected to increase over the years.

 

Rising incidence of leukemia and lymphoma and continuous research on hematopoietic stem cells are expected to drive market growth

As per 2017 report by Leukemia and Lymphoma Society, the U.S. alone is expected to account for a prevalence of 8,16,834 and incidence of 80,500 for lymphoma. Increasing rate of incidence is in turn, expected to increase the demand for hematopoietic stem cell transplantation thus, propelling growth of the hematopoietic stem cell transplantation (HSCT) market. Increasing awareness about stem cell therapies among the population is also expected to propel growth of the hematopoietic stem cell transplantation market. As per survey by World Network for Blood and Marrow Transplantation (WBMN), around one million hematopoietic stem cell transplantation procedures were performed during 2006 to 2014, which indicates potential opportunities for market players.

 

Request For A Sample Copy Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1250

 

Global Hematopoietic Stem Cell Transplantation Market Taxonomy

On the basis of indication:

Leukemia, Lymphatic disorder, Myeloma

Other non-malignant disorders (thalassemia, sickle cell anemia, Osteoporosis, Immunodeficiency syndrome)

On the basis of application:

Peripheral blood cells, Bone marrow, Umbilical cord blood

 

Increasing adoption of the growing trend of personalized medicine is expected to drive growth of the hematopoietic stem cells transplantation market. A collaborative research study on hematopoietic stem cell transplantation initiated by World Network for Blood and Marrow Transplantation (WBMN) in 2013 in the domain of promotion of access to hematopoietic stem cell transplantation, developed a donation guidance document, technical and scientific input on safety, and quality of HSCT as mentioned in annual report of the WBMN.

 

In March 2017, Gilead Sciences announced the acquisition of Kite Pharma, which produces products such as Axi-cel to treat non-Hodgkin lymphoma. Plasticell, which specializes in the development of stem cell technologies and cell-based therapies, announced entering into an agreement with Nan yang Technological University (NTU) in Singapore on March 2017, to advance its therapeutic stem cell pipeline. Plasticell also announced collaboration with Anthony Nolan, a research organization in blood cancer, to progress clinical development of Plasticell’s ex vivo expanded cord blood-derived hematopoietic stem cell product in December 2017. Also, GE Healthcare announced the introduction of Thaw CB1000, for thawing large volumes of cell therapies cryopreserved in cryo-bags majorly intended for use in research laboratory, in September 2017.

 

Important players present in the hematopoietic stem cell transplantation market

Major players operating in the hematopoietic stem cell transplantation market include Pluristem Therapeutics Inc., CellGenix Technologie Transfer GmbH, Kite Pharma Inc., Regen Biopharma Inc., BiolineRx, Cynata Therapeutics, Lonza Group Ltd, Cesca Therapeutics Inc, TiGenix N.V., Escape Therapeutics Inc., Bluebird Bio, and Cellular Dynamics International.

 

Click To Read More On Hematopoietic Stem Cell Transplantation (HSCT) Market

 

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

 

https://www.coherentmarketinsights.com/phase-xs/

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Human Papillomavirus (HPV) Infection Vaccines Market Best Productivity Supply Chain Relationship, Development by 2026

Human papillomavirus infection is most common sexually transmitted infection caused by HPV-related cancers such as cervical and genital cancer. Human papillomavirus infection vaccines are used to prevent genital wart, anal cancer, cervical cancer, and vaginal cancer. Three commercially available HPV prevention vaccine such as Gardasil and Gardasil 9 by Merck & Co., Inc. and Cervarix by GlaxoSmithKline plc, are proven to be highly effective in preventing of HPV infection and genital precancerous lesions. The adoption of preventive vaccines shifted the paradigm of diseases, and are expected to have a major impact in reducing the burden of cervical cancer, HPV-associated malignancies, and benign tumors. The key factors driving growth of the human papillomavirus infection vaccine market include large number of pipeline products, increasing research for therapeutic vaccine, governmental initiative for immunization program, and high prevalence of HPV-related infectious disease.

 

Request For Sample Pdf Of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1588

 

Human Papillomavirus (HPV) Infection Vaccines Market Driver

Large number of clinical trials conducted by pharmaceutical and biopharmaceutical companies are expected to fuel growth of the HPV infection vaccine market during the forecast period. For instance, Merck & Co., Inc., is conducting Phase III clinical trial for it quadrivalent human papillomavirus recombinant vaccine for type 6, 11, 16, and 18. Moreover, Shanghai Bovax Biotechnology Co., Ltd., is engaged in evaluating safety and primary immunogenicity of the quadrivalent human papillomavirus vaccine in female population of China. Currently studies are in phase I clinical trial. Furthermore, Serum Institute of India Pvt. Ltd., is developing tetravalent HPV vaccine, which is expected to provide protection of around 90% against HPV infections, which are prevalent in the emerging economies such as India and China.

 

Moreover, increasing research on therapeutic vaccine for treatment of HPV infection to address unmet medical need is expected to boost growth of the human papilloma virus (HPV) infection vaccines market. For instance, Profectus BioSciences, Inc., is engage in developing GeneVax prime/VesiculoVax, a therapeutic vaccine for HPV infection. The vaccine is expected to be effective against seven HPV types. Moreover, Inovio Pharmaceuticals, Inc., is investigating VGX-3100 as candidate for immunotherapy to demonstrate efficacy against cervical HSIL associated with HPV-16 and HPV-18. VGX-3100 is divalent DNA plasmid-based therapeutic vaccine, which completed phase 2b clinical trial in 2015 and initiated phase 3 in June 2017.

 

Governmental and non-governmental organization plays important role in increasing awareness through immunization program, in turn driving growth of the human papillomavirus infection vaccine market. For instance, in 2012, the Global Alliance for Vaccines and Immunization (GAVI) support for HPV vaccine introduction targeted to reach 30 million girls in emerging economies by 2020. In 2016, Joint UN Global Programme was set up for prevention of cervical cancer, which includes vaccination in high disease burden countries.

 

Human Papillomavirus (HPV) Infection Vaccines Market Regional Analysis

Regional segmentation of human papillomavirus (HPV) infection vaccine market by Coherent Market Insights, includes North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America comprises major share of the human papillomavirus infection treatment vaccine market, owing to high prevalence of cervical cancer, local market players and increasing governmental initiatives, followed by Europe. For instance, according to WHO 2016, currently 86% of America and 62% of European region girls have access to free HPV vaccination. Moreover, incidence of cervical cancer in Europe was 58,348 individuals per million in 2012.

 

Human Papillomavirus (HPV) Infection Vaccines Market Key Players

Major players operating in the HPV infection vaccine market include Merck & Co., Inc. and GlaxoSmithKline plc. The companies having the candidate for HPV vaccines are Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB and ISA Pharmaceuticals.

 

Click To Read More On Human Papillomavirus (HPV) Infection Vaccines Market

 

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com

 

https://www.coherentmarketinsights.com/phase-xs/

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Cast Removal Devices Market 2026 Key Findings, Regional Analysis, Top Key Players Profiles and Future Prospects

Cast removal devices are designed to cut cast material such as fiberglass, plastic or plaster and bandage that are used for rehabilitation of the fractured bones or ruptured tendons. It is mainly used by orthopedic surgeons in hospitals and clinics to cure musculoskeletal injuries caused due to road accidents and during sports practices. According to the U.S. Department of Health & Human Services report on January 2018, road traffic injuries are a huge economic burden on low and middle income economies and are estimated to cost US$ 518 billion globally.

 

In many areas in the emerging economies, technology has still not found there roots to grow and people use home remedies such as securing with wooden sticks instead of casting plaster. The development of hospital facilities in these areas will drive growth of cast removal device market. In November 2016, Stryker Corporation, one of the world's leading medical technology company, announced a multi-year collaboration with Indo UK Institute of Health's (IUIH) Medicity Program to serve greater access to affordable services to patients in India, which will also help in propelling growth of cast removal device market.

 

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1493

 

Cast Removal Device Market Taxonomy:

By Product Type:

  • Vacuum cutter

  • Saw cutter

  • Cast spreader

By Energy Source:

  • Battery powered (cordless)

  • Electric (corded)

By End Users:

  • Clinics

  • Hospitals

  • Rehabilitation centers

  • Other

 

Cast Removal Device Market Driver

Increase in frequency of road accidents and musculoskeletal injuries during sports is expected to drive growth of the cast removal devices market. According to a survey published by the World Health Organization (WHO) in Jan, 2018, over 3,400 people die on the world's roads every day and tens of millions of people are injured or disabled every year. Also, according to the John Hopkin’s Medicine, in the U.S., over 3.5 million children at the age of 14 and younger get hurt annually by playing sports or participating in recreational activities.

 

The strategies adopted by key market players to come up with innovative technologies such as noise free or debris free plaster cutters at affordable rates are lucrative opportunities for growth of the cast removal device market. Cast removal devices are scary and traumatic for most of the patients due to noise and blade rotation, however, OrthoPediatrics’s Quiet cast removal device was a major leap forward in technology in 2009. Shanghai Bojin Medical instrument Co., Ltd. aimed at coming up with products and solutions with reduced medical costs and lessening the financial burden of the patients.

 

Cast Removal Devices Market – Regional Analysis

The global cast removal market is regionally segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America holds the dominant position in cast removal device market due to local manufacturers and high incidence of road injuries. For instance, according to the Association for Safe International Road Travel, in 2016, 2.35 million people were injured or disabled every year due to road crash in the U.S. Asia Pacific is expected to be fastest growing market over the forecast period due to increasing prevalence of road accidents. For instance, according to the National Crime Records Bureau, the number of road accidents in 2008 was 415 thousands, which increased to 440 thousands by 2012 in India.

 

Cast Removal Devices Market – Competitors

The major players operating in the cast removal devices market include DeSoutter medical, Erbrich Instrumente GmbH, Ermis MedTech, Hanshin Medical Co.,ltd, HEBUmedical GmbH, Osimed medical, Rimec S.R.L., Shanghai Bojin Medical instrument Co., Ltd., Stryker, and TREU-Instrumente GmbH.

 

Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/1493

 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.